Maeda Yumi, Makino Masahiko, Crick Dean C, Mahapatra Sebabrata, Srisungnam Sopa, Takii Takemasa, Kashiwabara Yoshiko, Brennan Patrick J
Department of Microbiology, Leprosy Research Center, National Institute of Infectious Diseases, Higashimurayama, Tokyo 189-0002, Japan.
Infect Immun. 2002 Aug;70(8):4106-11. doi: 10.1128/IAI.70.8.4106-4111.2002.
A novel Mycobacterium leprae lipoprotein LpK (accession no. ML0603) was identified from the genomic database. The 1,116-bp open reading frame encodes a 371-amino-acid precursor protein with an N-terminal signal sequence and a consensus motif for lipid conjugation. Expression of the protein, LpK, in Escherichia coli revealed a 33-kDa protein, and metabolic labeling experiments and globomycin treatment proved that the protein was lipidated. Fractionation of M. leprae demonstrated that this lipoprotein was a membrane protein of M. leprae. The purified lipoprotein was found to induce production of interleukin-12 in human peripheral blood monocytes. The studies imply that M. leprae LpK is involved in protective immunity against leprosy and may be a candidate for vaccine design.
从基因组数据库中鉴定出一种新型麻风分枝杆菌脂蛋白LpK(登录号:ML0603)。1116 bp的开放阅读框编码一个371个氨基酸的前体蛋白,该蛋白具有N端信号序列和脂质结合的共有基序。该蛋白LpK在大肠杆菌中的表达产生了一种33 kDa的蛋白,代谢标记实验和球蛋白处理证明该蛋白发生了脂化。麻风分枝杆菌的分级分离表明,这种脂蛋白是麻风分枝杆菌的一种膜蛋白。发现纯化的脂蛋白可诱导人外周血单核细胞产生白细胞介素-12。这些研究表明,麻风分枝杆菌LpK参与麻风病的保护性免疫,可能是疫苗设计的候选对象。